Karolinska Development AB (publ) (STO:KDV)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.2800
-0.0095 (-3.28%)
At close: Feb 10, 2026
Market Cap183.12M -31.5%
Revenue (ttm)1.74M -7.5%
Net Income-135.74M
EPS-0.50
Shares Out654.00M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume419,687
Average Volume1,085,451
Open0.2920
Previous Close0.2895
Day's Range0.2800 - 0.2995
52-Week Range0.2535 - 1.3440
Beta0.39
RSI36.69
Earnings DateFeb 13, 2026

About Karolinska Development AB

Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, medical innovations, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio com... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2003
Employees 8
Stock Exchange Nasdaq Stockholm
Ticker Symbol KDV
Full Company Profile

Financial Performance

Financial Statements